Inhibition of autophagic flux by the curcumin analog EF‐24 and its antiproliferative effect on MCF‐7 cancer cells
Journal of Biochemical and Molecular Toxicology · 2023
DOI: 10.1002/jbt.23307 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2023. Verfasst von Jun Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, College of Bioengineering, Henan University of Technology, Zhengzhou, China. Hauptthemen laut MEDLINE: Curcumin, Breast Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: Science and Technology Planning Project of Henan Province, Innovative Funds Plan of Henan University of Technology.
Abstract (Originalsprache)
5‐Bis[(2‐fluorophenyl)methylene]‐4‐piperidinone (EF‐24) is a curcumin analog, which was identified for its physiochemical stability and diverse pharmacological functions. In the present study, EF‐24 was added to the breast cancer cell line MCF‐7 and its cellular effects were characterized. The results indicated that EF‐24 possessed antiproliferative and antimigratory activities on MCF‐7 cells as determined by MTT assay, wound healing, and transwell assay, respectively. In addition, the autophagosomal vesicles could be detected by acridine orange staining and electron microscope analysis in EF‐24‐treated cells. Conversion of LC3‐I to LC3‐II was also investigated following EF‐24 treatment of the cells. However, the expression analysis of p62 and LC3 revealed that EF‐24 could inhibit autophagic flux in MCF‐7 cells. Confocal microscopy suggested that EF‐24 could inhibit the degradation of autophagic vesicles by blocking the fusion of autophagosomes with lysosomes. EF‐24 could also induce apoptosis of MCF‐7 cells as determined by Hoechst 33342 staining, flow cytometry analysis, and western blot analysis. Moreover, treatment of the cells with the autophagy inhibitor 3‐MA enhanced the PARP1 cleavage of EF‐24‐treated MCF‐7 cells, which indicated the crosstalk between autophagy and apoptosis in breast cancer cells. Additional investigation of EF‐24 should be performed in future studies to assess its antiproliferation and antimigratory effects on MCF‐7 cells. However, the current results provide a solid foundation for the potential in vivo anticancer activity of this compound.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, College of Bioengineering, Henan University of Technology, Zhengzhou, China.
- Division of Aquaculture and Genetic Breeding, Henan Academy of Fishery Sciences, Zhengzhou, China.
Förderung
- Science and Technology Planning Project of Henan Province
- Innovative Funds Plan of Henan University of Technology
Zitieren
APA
Li, J., Wang, S. H., Liu, Y. T., Zhang, Q., & Zhou, G. Z. (2023). Inhibition of autophagic flux by the curcumin analog EF‐24 and its antiproliferative effect on MCF‐7 cancer cells. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23307
Vancouver
Li J, Wang SH, Liu YT, Zhang Q, Zhou GZ. Inhibition of autophagic flux by the curcumin analog EF‐24 and its antiproliferative effect on MCF‐7 cancer cells. Journal of Biochemical and Molecular Toxicology. 2023. doi:10.1002/jbt.23307
BibTeX
@article{Li2023,
author = {Li, Jun and Wang, Song-He and Liu, Yang-Ting and Zhang, Qin and Zhou, Guang-Zhou},
title = {Inhibition of autophagic flux by the curcumin analog EF‐24 and its antiproliferative effect on MCF‐7 cancer cells},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2023},
doi = {10.1002/jbt.23307}
}
EUVIMED